Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
26,839,702
-
Share change
-
+7,049,678
-
Total reported value
-
$211,145,000
-
Put/Call ratio
-
12%
-
Price per share
-
$7.94
-
Number of holders
-
53
-
Value change
-
+$56,683,867
-
Number of buys
-
27
-
Number of sells
-
22
Institutional Holders of AVADEL PHARMACEUTICALS - COM (AVDL) as of Q1 2020
As of 31 Mar 2020,
AVADEL PHARMACEUTICALS - COM (AVDL) was held by
53 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,839,702 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, Avoro Capital Advisors LLC, Vivo Capital, LLC, ACUTA CAPITAL PARTNERS, LLC, BRANDES INVESTMENT PARTNERS, LP, COWEN AND COMPANY, LLC, VR Adviser, LLC, RENAISSANCE TECHNOLOGIES LLC, Invesco Ltd., and DEUTSCHE BANK AG\.
This page lists
55
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.